Nasal sprays and drops have been in use since the early 1900s to alleviate the symptoms of allergic rhinitis, upper respiratory tract infections, and nasal polyps. The most common of these preparations, widely available as non-prescription drugs, are decongestants containing one or more sympathomimetic compounds. Corticosteroid nasal sprays, available only by prescription, are a second group of compounds which are used in the treatment of nasal polyps and allergic rhinitis.
The potential health consequences ofchronic use of these nasal preparations are not fully known. Common adverse reactions to corticosteroid preparations include irritation and dryness of the nasal mucosa, although perforation of the nasal septum has also been noted.' 2 Toohill et a13 have suggested that the long-term use of topical decongestants may be related to the development of nasal polyposis and ethmoiditis. More recently, Hayes et at' reported a five-fold excess risk of sinonasal cancer among men with a history of nasal spray use, although no excess risk was found among women with such a history.
As part of a case-control study designed to investigate formaldehyde as a potential risk factor for pharyngeal and sinonasal cancer,5 we assessed the history of nasal preparation use and rhinologic conditions among respondents. This report presents results concerning the use of nasal preparations as a risk factor for sinonasal cancer.
Methods
Cases were identified by the Cancer Surveillance System of the Fred Hutchinson Cancer Research Center, a population-based cancer registry operated as part of the Surveillance, Epidemiology and End Results programme of the National Cancer Institute. The registry identifies 98-99% of all incident cancer cases occurring among residents of 13 counties of western Washington. Patients who were eligible for participation in the study were all cases of sinonasal cancer (ICD-06 sites 160.0-160.9) who were (a) diagnosed between January 1979 and December 1983, (b) residents of western Washington when diagnosed, (c) between 20 and 74 years ofage at diagnosis, and (d) lived in a residence that had a telephone. Seventy-eight eligible sinonasal cancer cases were identified.
Attempts (n = 6), adenocarcinoma (n = 6), lymphoma (n = 6), or melanoma (n = 2). Six cases were histologically unspecified. As a group, sinonasal cancer cases were slightly older than the controls but were similar to controls with respect to sex and racial distributions. Fewer sinonasal cancer cases than controls had received some college or technical education. recurrent nosebleeds (RR=1 4; 95% CI = 0 1-11 4). The relative risk associated with the use of nasal preparations did not vary appreciably with adjustment for sex, alcohol consumption, smoking, wood dust exposure, or the sinonasal conditions mentioned above.
The use of nasal preparations was strongly associated with cancer of the nasal sinuses (RR = 5-2; 95% CI= 19-13-4) (ICD-0 site codes 160.2-160.7; n=23 cases). We found a relative risk of 1-7 (95% CI = 0-5-5-5) for tumours of the nasal cavity (ICD-0 site code 160.0, n=24 cases), and 7 9 (95% CI= 0-8-84 7) for tumours of other sinonasal sites (ICD-0 site codes 160.1 and 160.8, n = 4 cases). An examination of the variation in relative risk by histologic type revealed the strongest association with adenocarcinoma (RR = 8&0; 95% CI = 1 -2-50-2); the relative risks were smaller for squamous cell (RR= 3-6, 95% CI= 14-9 4) and other histologic types (RR= 2-3, 95% CI = 0 6-7 7).
To investigate whether the risk of sinonasal cancer increased with increasing use ofnasal preparations, we examined both the frequency (weeks per year) and duration (number of years) of nasal preparation use. The risk of sinonasal cancer increased with increasing weeks per year of use and increasing years of use. Compared with respondents who reported using nasal preparations less than one week per year, those who reported 26 or more weeks per year of use had a relative risk of 3 8. A six-fold increase in relative risk was observed for respondents who reported ten or more years of use compared with those who had used nasal preparations I year or less. Since nasal preparations may be used to relieve symptoms brought on by a number of medical conditions which may be risk factors for sinonasal cancer, we repeated this analysis excluding nine cases and 32 controls with a history of nasal polyps or other ear-nose-throat Clifton H Strader, Thomas L Vaughan, and Andy Stergachis problems (one case with deviated septum, five controls with recurrent nosebleeds, one control with throat polyps, two controls with deviated septa). The exclusion of these subjects had little impact on the magnitude of the observed risks.
An examination of total weeks of nasal preparation use (frequency x duration) revealed an almost ninefold increase in risk for subjects who had 520 or more total weeks of use. The magnitude of this risk reflects the close association between frequency and duration of use; subjects who reported using nasal preparations for many years also tended to use them for many weeks per year. When next-of-kin interviews were excluded from analysis, the RR associated with 520 or more total weeks of use was 7-0 (table 4). Brinton et alt2 reported an increased risk of sinonasal cancer associated with a history of sinus trouble, nasal polyps and recurrent nose-bleeds. However, we found only a weak association between a history of nasal polyps, hayfever, or other ear-nose-throat problems (such as deviated septum and epistaxis) and sinonasal cancer (table 3) , and the association between the use of nasal preparations and sinonasal cancer persisted when respondents with a history of nasal polyps or ear-nose-throat problems were omitted from the analysis.
Prolonged or excessive use of topical decongestants can result in decreased vasoconstriction followed by increased rebound vasodilation. I5 The resultant nasal congestant promotes continued use of the preparations. In our study, frequency and duration of use were closely associated: one-half of the cases who reported using nasal preparations for two or more years also reported that they used them for 26 or more weeks per year.
The possibility that the observed association between nasal preparation use and an increased risk of 
